Regulatory Consultants and What They Get Wrong | Thomas Moore, PhD
Early-stage medtech founders often treat regulatory strategy as a checklist item. That mistake can cost years, capital, and credibility. In this episode, I sit down with Thomas Moore, founder of PTL Solutions, to understand why regulatory strategy is actually a business roadmap and how founders can engage with it intelligently without outsourcing their judgment.
Regulatory strategy is often framed as a compliance hurdle — something to outsource, check off, and move past. But as Thomas Moore, PhD explains, that mindset quietly introduces risk across the entire business.
With over two decades in medical device development, Thomas has seen what happens when founders receive a beautifully written regulatory document they can’t defend, explain, or adapt. In this conversation, he reframes regulatory strategy as a living roadmap — one that connects product design, clinical evidence, quality systems, investor confidence, and FDA credibility.
This episode is especially relevant for early-stage medtech founders navigating limited budgets, compressed timelines, and high stakes. Thomas shares why founders don’t need to do everything themselves — but why they can’t afford to be hands-off either. From pre-subs to predicate strategy to “spinning plates” across functions, this conversation gives founders language, structure, and confidence to engage regulators and consultants from a position of clarity.
If you’re building a regulated product and trying to move fast without stepping on landmines, this episode will help you think more clearly about where regulatory fits — and why it’s inseparable from business strategy.
Subscribe to LifeSci Continuum for founder-level conversations on commercialization, regulation, and building durable life-science companies.
Follow Bill: / founderandcdo
Contact Bill: https://meshagency.com/lets-connect/
Video Podcast: / @billschickfcmo
Audio Podcast: https://www.buzzsprout.com/2380430
Follow Thomas: / thomas-moore-phd